Skip to main content

Table 1 Patient characteristics

From: Quantitative assessment of paravalvular regurgitation following transcatheter aortic valve replacement

 

AVR

 

TAVI

 

P

n = 31

n = 56

Age (SD)

80

4

84

6

<.01

Male (%)

15

48

34

61

.27

STS Score (SD)

8.7

7.7

8.9

5.4

.45

Hypertension (%)

26

84

50

90

.47

Previous MI (%)

5

16

12

21

.55

COPD (%)

15

48

23

41

.51

Renal Impairment (%)

11

35

18

32

.76

Atrial Fibrillation (%)

8

26

20

36

.34

Diabetes (%)

15

48

22

39

.42

Redo (%)

0

0

23

41

<.01

Previous CVA/TIA (%)

6

19

17

31

.27

NYHA Class (SD)

2.7

0.6

2.7

0.7

.42

PAH (%)

11

36

14

25

.30

  1. BMI – Body Mass Index; CAD – Coronary Artery Disease; COPD - Chronic Obstructive Pulmonary Disease; MI – Myocardial Infarction; Neuro CVA- Previous TIA or CVA; PAH – Pulmonary Artery Hypertension; PCI - Percutaneous coronary intervention; Redo – Previous Cardiac Surgery; STS – Society of Thoracic Surgeons Score.